Synthesis of cholesteryl doxorubicin and its anti-cancer activity

Bioorganic and Medicinal Chemistry Letters

Volumn 27, Issue 4, 2017, Pages 723-728

  Choi, Jong Soo ^a   Doh, Kyung Oh ^b   Kim, Bieong Kil ^c   Seu, Young Bae ^a  

^a Kyungpook National University   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Antineoplastic drug; Cholesterol; Doxorubicin

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CHOLESTERYL DOXORUBICIN; DOXORUBICIN; DOXORUBICIN DERIVATIVE; UNCLASSIFIED DRUG; CHOLESTEROL; LIPOSOME;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG SYNTHESIS; FEMALE; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN CELL; IC50; MCF-7 CELL LINE; MDA-MB-231 CELL LINE; SYSTEMATIC REVIEW; A-549 CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; SYNTHESIS; TUMOR CELL LINE;

A549 CELLS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHOLESTEROL; DOXORUBICIN; HELA CELLS; HUMANS; LIPOSOMES; MCF-7 CELLS; MICROSCOPY, FLUORESCENCE;

EID: 85010222375     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2017.01.048     Document Type: Article

References (24)

1. 1 Malla, S., Niraula, N.P., Singh, B., Liou, K., Sohng, J.K., Microbiol Res, 165, 2010, 427.
2. 2 Vincenzi, B., Frezza, A.M., Santini, D., Tonini, G., Expert Opin Emerg Drugs, 15, 2010, 237.
3. 3 Biersack, H., Jensen, S., Gromova, I., Nielsen, I.S., Westergaard, O., Andersen, A.H., Proc Natl Acad Sci U S A, 93, 1996, 8288.
4. 4 Nelson, W.G., Liu, L.F., Coffey, D.S., Nature, 322, 1986, 187.
5. 5 Raoul, J.L., Heresbach, D., Bretagne, J.F., et al. Cancer, 70, 1992, 585.
6. 6 Rahman, A., Carmichael, D., Harris, M., Roh, J.K., Cancer Res, 46, 1986, 2295.
7. 7 Meissner, K., Sperker, B., Karsten, C., et al. J Histochem Cytochem, 50, 2002, 1351.
8. 8 Ibsen, S., Zahavy, E., Wrasdilo, W., Berns, M., Chan, M., Esener, S., Pharm Res, 27, 2010, 1848.
9. 9 Sun, K., Wang, J., Zhang, J., Hua, M., Liu, C.S., Chen, T.Y., Int J Biol Macromol, 49, 2011, 173.
10. 10 Abu Ajaj, K., El-Abadla, N., Welker, P., et al. Eur J Cancer, 48, 2012, 2054.
11. 11 Yousefpour, P., Atyabi, F., Vasheghani-Farahani, E., Movahedi, A.A., Dinarvand, R., Int J Nanomed, 6, 2011, 1977.
12. 12 Barenholz, Y., J Control Release, 160, 2012, 117.
13. 13 Chhikara, B.S., St Jean, N., Mandal, D., Kumar, A., Parang, K., Eur J Med Chem, 46, 2011, 2037.
14. 14 Garnier-Suillerot, A., Marbeuf-Gueye, C., Salerno, M., et al. Curr Med Chem, 8, 2001, 51.
15. 15 McMullen, T.P., Lewis, R.N., McElhaney, R.N., Biophys J, 79, 2000, 2056.
16. 16 Kuang, Y., Liu, J., Liu, Z., Zhuo, R., Biomaterials, 33, 2012, 1596.
17. 17 Rao, Z., Taguchi, T., Colloids Surf B Biointerfaces, 97, 2012, 248.
18. 18 Li, X.M., Chen, M.M., Yang, W.Z., Zhou, Z.M., Liu, L.R., Zhang, Q.Q., Colloids and Surfaces B-Biointerfaces, 92, 2012, 136.
19. 19 Kim, B.K., Seu, Y.B., Bae, Y.U., et al. Int J Mol Sci, 15, 2014, 7293.
20. 20 Che, C., Yang, G., Thiot, C., et al. J Med Chem, 53, 2010, 2814.
21. 21 Chen, Q., Sowa, D.A., Gabathuler, R., Synth Commun, 33, 2003, 2391.
22. 22 Kim, B.K., Doh, K.O., Nam, J.H., et al. Bioorg Med Chem Lett, 19, 2009, 2986.
23. 23 Farquhar, D., Cherif, A., Bakina, E., Nelson, J.A., J Med Chem, 41, 1998, 965.
24. 24 Gottesman, M.M., Fojo, T., Bates, S.E., Nat Rev Cancer, 2, 2002, 48.